Although TERT promoter mutations have been described in only 0.9% of breast cancers (15), in studies by Gerald (16), Zhong (17), Krings, and Chen (18), 15 of 17 cases (88%) harbored TERT promoter alterations. This evidence concerns the gene TERT and breast carcinoma.